Creative Biogene Launches Custom RNA Services to Advance Research and Therapeutic Development

Creative Biogene has announced the release of its custom RNA services, establishing a foundation for transforming cutting-edge scientific discoveries into industry-grade tools and service capabilities. In today's rapidly evolving field of RNA research, RNA has transformed from a mere research subject into a key element in drug development and therapeutic applications. With the continuous emergence of RNA technologies such as mRNA vaccines, circular RNA, and self-amplifying RNA, the demand for customized RNA solutions has reached unprecedented levels. To meet this demand, Creative Biogene has launched a comprehensive customized RNA service, providing researchers and developers with tailored solutions that bridge basic research and practical applications.

Creative Biogene offers a comprehensive range of solutions specializing in custom RNA services, including the synthesis and customization of mRNA, saRNA, circRNA, and RNA interference molecules. Their expert team is dedicated to meeting the unique needs of researchers across various fields, from academic laboratories to pharmaceutical companies. Creative Biogene's unique strength lies in its rigorous control over quality and consistency. Each batch of RNA products undergoes comprehensive quality control measures to ensure its purity and functionality, allowing researchers to expect batch-to-batch consistency to meet industry standards. The core of Creative Biogene's custom RNA services relies on its advanced engineering capabilities, enabling sophisticated modifications to RNA to meet diverse application needs.

From introducing specific nucleotides to optimizing structural features, each RNA molecule can be finely regulated to enhance its stability and efficacy for a wide range of experimental and clinical uses. Furthermore, the service offers high flexibility, providing production scales from micrograms to grams to meet the needs of both basic research and large-scale therapeutics. The Custom RNA Service provides dedicated support for miRNA and circRNA research, including specialized services such as precise sequence design and expression profiling of miRNAs to elucidate their roles in gene regulation and disease progression. The launch of the Custom RNA Service by Creative Biogene also marks the establishment of its one-stop Contract Development and Manufacturing Organization platform, which integrates all stages of RNA drug development.

This platform integrates all stages of RNA drug development, from sequence design and in vitro transcription to GMP-grade manufacturing and validation. CDMO services encompass comprehensive analytical services for assessing RNA integrity and ensuring compliance with stringent regulatory requirements. The introduction of lipid nanoparticle encapsulation technology represents a significant advancement in therapeutic drug delivery, enabling efficient multi-component co-encapsulation to meet diverse therapeutic needs. Creative Biogene is committed to becoming a leader in the RNA services market with a team consisting of scientists with extensive expertise in molecular biology, RNA chemistry, and drug development. The company is dedicated to providing researchers with the tools they need to translate their findings from experimental discoveries into practical applications, based on rigorous scientific principles and operational excellence.

By providing highly customized RNA solutions, Creative Biogene not only enhances global research capabilities but also drives the transformation of innovative ideas into impactful therapies. The company's scale-up expertise and unique mRNA, oligonucleotide and plasmid production capabilities support companies focused on therapeutic, vaccine, diagnostic, and biopharmaceutical breakthroughs. This development is particularly significant given the growing importance of RNA technologies in modern medicine and research, where precise customization and reliable production are essential for advancing both basic science and clinical applications. The availability of these specialized services addresses a critical need in the scientific community for reliable, high-quality RNA products that can accelerate research timelines and improve experimental outcomes across multiple disciplines.